These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7515011)

  • 1. Comparison of protein synthesis profiles in chronic lymphocytic leukaemia cells and B-lymphocytes from peripheral blood, cord blood and tonsil.
    Saunders FK; Lawry J; Winfield DA; Goepel JR; Hancock BW; Sharrard RM; Goyns MH
    Experientia; 1994 May; 50(5):493-6. PubMed ID: 7515011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2D-gel analysis of proteins in chronic lymphocytic leukemia cells and normal B-lymphocytes.
    Saunders FK; Sharrard RM; Winfield DA; Lawry J; Goepel JR; Hancock BW; Goyns MH
    Leuk Res; 1993 Mar; 17(3):223-30. PubMed ID: 7680735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
    Roliński J; Rupniewska ZM; Wasik-Szczepanek E
    Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface and molecular expression of complement-receptor type 2 of neoplastic CD5+ B cells in chronic lymphocytic leukemia.
    Tooze JA; Bevan DH; Lever AM
    Ann N Y Acad Sci; 1992 May; 651():494-7. PubMed ID: 1376070
    [No Abstract]   [Full Text] [Related]  

  • 5. 2D-gel analysis of protein synthesis profiles of different stages of chronic lymphocytic leukaemia.
    Saunders FK; Winfield DA; Goepel JR; Hancock BW; Sharrard RM; Goyns MH
    Leuk Lymphoma; 1994 Jul; 14(3-4):319-22. PubMed ID: 7950921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
    Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F
    Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
    Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
    J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis.
    Gottardi D; Alfarano A; De Leo AM; Stacchini A; Aragno M; Rigo A; Veneri D; Zanotti R; Pizzolo G; Caligaris-Cappio F
    Br J Haematol; 1996 Sep; 94(4):612-8. PubMed ID: 8826882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory capability of murine CLL-like CD5+ B cells.
    Phillips J; Raveché E
    Ann N Y Acad Sci; 1992 May; 651():488-90. PubMed ID: 1376068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterization of human B-lymphocyte subpopulations, particularly human CD5+ B-lymphocyte subpopulation within the mantle zones of secondary follicles.
    Abe M; Tominaga K; Wakasa H
    Leukemia; 1994 Jun; 8(6):1039-44. PubMed ID: 7516026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40.
    Gagro A; McCloskey N; Challa A; Holder M; Grafton G; Pound JD; Gordon J
    Immunology; 2000 Oct; 101(2):201-9. PubMed ID: 11012773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of normal and malignant CD5+ B lymphocytes.
    Riva M; Schena M; Bergui L; Tesio L; Gaidano G; Marchisio P; Caligaris-Cappio F
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):289-91. PubMed ID: 3265499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.
    Lavabre-Bertrand T; Janossy G; Exbrayat C; Bourquard P; Duperray C; Navarro M
    Leukemia; 1994 Sep; 8(9):1557-63. PubMed ID: 7522294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T; Vanbervliet B; Durand I; Banchereau J
    Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scoring system for the classification of CD5-B CLL versus CD5+ B CLL and B PLL.
    Salomon-Nguyen F; Valensi F; Merle-Beral H; Flandrin G
    Leuk Lymphoma; 1995 Feb; 16(5-6):445-50. PubMed ID: 7540458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
    Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
    Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.